New 52 Week Low Today

Virpax Pharmaceuticals Inc VRPX:NASDAQ

RT Quote | NASDAQ | USD
Last | 04/19/21 EDT
4.26quote price arrow down-0.06 (-1.39%)
Volume
98,261
52 week range
3.96 - 8.24

...

Loading . . .
  • Open4.19
  • Day High4.31
  • Day Low3.96
  • Prev Close4.26
  • 52 Week High8.24
  • 52 Week High Date02/17/21
  • 52 Week Low3.96
  • 52 Week Low Date04/19/21

Key Stats

  • Market Cap21.09M
  • Shares Out4.95M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open4.19
  • Day High4.31
  • Day Low3.96
  • Prev Close4.26
  • 52 Week High8.24
  • 52 Week High Date02/17/21
  • 52 Week Low3.96
  • 52 Week Low Date04/19/21
  • Market Cap21.09M
  • Shares Out4.95M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.88
  • P/E (TTM)-4.85
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-4.196M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-37.13%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Virpax Pharmaceuticals Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Virpax Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing pharmaceutical product candidates for pain management by developing and delivering non-opioid and non-addictive pharmaceutical products. Its products include Epoladerm, OSF200, Probudur, NES100, PES200 and MMS019. Epoladermis is developed as a topical nonsteroidal anti-inflammatory drug (NSAID) treatment for acute pain. OSF200 utilizes the same transdermal delivery system as...
Address
1554 Paoli Pike #279, #279
West Chester, PA
19380
United States